Passage Bio shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Passage Bio
Tip: Access up to 7 years of quarterly data
All positions including Passage Bio held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Passage Bio by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $27k | 27k | 1.01 |
| 2023-09-30 | $18k | 27k | 0.66 |
| 2023-06-30 | $26k | 28k | 0.94 |
| 2023-03-31 | $26k | 28k | 0.96 |
| 2022-12-31 | $40k | 29k | 1.38 |
| 2022-06-30 | $242k | 102k | 2.36 |
| 2022-03-31 | $458k | 148k | 3.10 |
| 2021-12-31 | $875k | 138k | 6.35 |
| 2021-09-30 | $1.2M | 120k | 9.96 |
| 2021-03-31 | $1.3M | 76k | 17.48 |
| 2020-12-31 | $2.5M | 97k | 25.57 |
| 2020-09-30 | $192k | 15k | 13.08 |